CD20
Image Gallery
[ (||image_reduire{0,60}|inserer_attribut{alt,CD20 positivity in a large cell lymphoma}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,CD20 immunostaing in follicular lymphoid hyperplasia}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,CD20 immunostaining of pulmonary follicular lymphoid hyperplasia}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,CD20+ nodules in progreesive transformation of germinal centers (...)}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,CD20+ nodules in progreesive transformation of germinal centers (...)}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,CD20+ nodules in progreesive transformation of germinal centers (...)}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,CD20+ nodules in nodular lymphocyte predominant Hodgkin lymphoma}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,CD20 in lung: slight bronchi-associated lymphoid tissue (BALT) (...)}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,CD20 immunostaining of the spleen: lymphoid follicles of the white pulp are (...)}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,CD20 immunostaining of a normal tonsil}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,CD20 immunostaining in nodal follicular lymphoid hyperplasia}) ]
See MS4A1 (MIM.112210)
Therapeutics
monoclonal antibodies
- rituximab